586
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma

, , , , , & show all
Pages 491-496 | Received 12 Jun 2012, Accepted 27 Jul 2012, Published online: 28 Sep 2012

References

  • Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009;114:501–510.
  • Goda JS, Le LW, Lapperrier NJ, . Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy:efficacy and toxicity. Int J Radiat Oncol Biol Phys 2011;81:e659–e666.
  • Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 2011;79:650–659.
  • Nam H, Ahn YC, Kim YD, . Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol 2009;90: 236–241.
  • SPSS for Windows 17.0. Chicago: SPSS, Inc.; 2008.
  • Pfeffer MR, Rabin T, Tsvang L, Orbital lymphoma: is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys 2004;60:527–530.
  • Zhou P, Ng AK, Silver B, . Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2005;63:866–871.
  • Uno T, Isobe K, Shikama N, . Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer 2003;98:865–871.
  • Fung CY, Tarbell NJ, Lucarelli MJ, . Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 2003;57:1382–1391.
  • Bayraktar S, Bayraktar UD, Stefanovic A, . Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol 2011;152:72–80.
  • Le QT, Eulau SM, George TI, . Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 2002; 52:657–663.
  • Bolek TW, Moyses HM, Marcus RB Jr, . Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44:31–36.
  • Martinet S, Ozsahin M, Belkacemi Y, . Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:892–898.
  • Yamashita H, Nakagawa K, Asari T, . Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 2008;87:412–417.
  • Son SH, Choi BO, Kim G, . Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Int J Radiat Oncol Biol Phys 2010;77:86–91.
  • Stafford SL, Kozelsky TF, Garrity JA, . Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 2001;59: 139–144.
  • Pelloski CE, Wilder RB, Ha CS, . Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 2001;59:145–151.
  • Esik O, Ikeda H, Mukai K, . A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol 1996;38:13–18.
  • Kennerdell JS, Flores NE, Hartsock RJ. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa. Ophthal Plast Reconstr Surg 1999;15:129–133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.